Internal medicine journal
-
Internal medicine journal · Jan 2024
Identifying the real-world challenges of dysplasia surveillance in inflammatory bowel disease: a retrospective cohort study in a tertiary health network.
Dysplasia surveillance in inflammatory bowel disease (IBD) is often suboptimal and deviates from guidelines. ⋯ Dysplasia surveillance in the IBD population remains an area of improvement given the current national guidelines. IBD specialists are more likely to perform dye chromoendoscopy than other endoscopists/gastroenterologists. Dysplasia rates in this real-world contemporary setting are less than expected in historical studies and may represent improvements in IBD management principles and medications.
-
Internal medicine journal · Jan 2024
Primary care management post Gestational Diabetes in Australia.
Women with a history of gestational diabetes (GD) have a high risk of developing diabetes and subsequent cardiovascular disease (CVD). ⋯ Screening for diabetes and hyperlipidaemia was suboptimal in this high-risk cohort of women with prior GD. Improved messaging that women with a GD diagnosis are at high cardiovascular risk may improve subsequent screening.
-
Internal medicine journal · Jan 2024
Prescribing of antivirals for COVID-19 in a South Australian local health network according to statewide guidelines.
Antiviral drugs were rapidly implemented into clinical practice for the treatment of high-risk patients with COVID-19, prompting the development of statewide guidelines. This South-Australian study reviewed guideline adherence, assessed prescribing patterns and highlighted the inappropriate management of relative drug-drug interactions and dosing for renal function. Additionally, it evaluated the impact of inappropriate antiviral drug use and suggested methods to improve quality use of medicines.
-
Internal medicine journal · Jan 2024
Trends in intravenous immunoglobulin use in New South Wales, Australia.
Intravenous immunoglobulin (IVIg) is a critical replacement therapy for immunodeficiencies and immunomodulatory treatment for autoimmune and inflammatory diseases. Adequate supply of IVIg is a global issue, necessitating supply restrictions. In Australia, despite strict criteria for use, demand for IVIg has increased over time and exceeds domestic supply. ⋯ Clinically acceptable measures to improve management of IVIg supply are needed including optimising dose, frequency and duration of treatment. Formal evaluation of IVIg versus alternatives, including cost-effectiveness and comparative efficacy, is warranted.
-
Internal medicine journal · Jan 2024
"Selection Into Training Will Always Be an Inexact Process": A survey of Directors of Physician Education on selection into Basic Physician Training in Australia and New Zealand.
Despite being one of the largest medical specialty training programmes in Australasia, there is no standardised method for selection into Basic Physician Training (BPT), and limited data exist regarding current practices. ⋯ BPT sites should critically evaluate their selection methods, and more research in this field is needed to establish best practice.